The Effect of Biologic Agents on Steatotic Liver Disease in Patients with Inflammatory Bowel Disease: A Prospective, Open-Label Comparative Trial.
Papaefthymiou A, Sarrou S, Pateras K, Vachliotis ID, Agrotis G, Sgantzou IK, Perifanos G, Kapsoritakis A, Speletas M, Vlychou M, Dalekos GN, Potamianos S, Goulas A, Kountouras J, Polyzos SA.
Papaefthymiou A, et al. Among authors: vachliotis id.
Pharmaceuticals (Basel). 2024 Oct 25;17(11):1432. doi: 10.3390/ph17111432.
Pharmaceuticals (Basel). 2024.
PMID: 39598344
Free PMC article.